FROVA
Print Print this page

Frequently asked questions about Menstrual Migraine

Q: What is a migraine?
A: A migraine is a common, recurrent, disabling headache disorder that can last from 4 to 72 hours.1 There are a number of characteristics that are typical of a migraine.1 These characteristics include moderate-to-severe pain on one side of the head that may throb. Exertion during routine physical activities—such as walking or climbing stairs—can make it worse. Migraines are often accompanied by nausea, vomiting, and a sensitivity to light and sound.

Some migraines may come with visual disturbances known as aura.1 Menstrual Migraine is typically without aura.1 Characteristics of an aura may include flickering lights, spots, or lines that appear before the eyes, or loss of vision in some cases.1 Many people feel they must lie down in a darkened room to help alleviate their migraine.2 While migraines are not life threatening, they can cause major disruptions to your personal and professional life.

Q: What causes a migraine?
A: Migraines are caused by a chemical imbalance in the brain that causes the blood vessels in your head to expand, resulting in pain.3 Some common triggers that can help bring on a migraine include alcohol (red wine, champagne), too much caffeine, stress, noise, lighting, eyestrain, changes in the weather, foods such as chocolate, aged cheese, nuts, cured meats, onions, and food additives such as MSG, aspartame, and nitrates.2,4,5 In addition to these triggers, changes in hormone levels may play a role in migraine attacks associated with a woman’s period, often referred to as Menstrual Migraine.6,7

Q: What is Menstrual Migraine?
A: There are actually two types of Menstrual Migraines—Menstrually Related Migraine (MRM) and Pure Menstrual Migraine (PMM). A Menstrually Related Migraine is a headache of moderate-to-severe pain intensity that happens during a certain window of time around the period and at other times of the month as well.1 A Pure Menstrual Migraine is similar in every respect, but occurs during the time around your period.1

Q: What causes Menstrual Migraine?
A: The exact causes of Menstrual Migraine are uncertain, but there seems to be a connection between changes in hormone levels around menstruation and migraine. Studies have suggested that it may have something to do with changes in hormone levels, which normally occur right before the period starts.6,7 In those women who are likely to suffer from migraine, this can act as a hormonal trigger.6,7

Q: How common is Menstrual Migraine?
A: Approximately 21 million women in the United States suffer from migraines,8 and about 60% of them suffer from Menstrually Related and Pure Menstrual Migraines combined.9,10

Q: Are there distinguishing features between Menstrual Migraines and migraines that occur at other times?
A: Yes, there are. Menstrual Migraines have been reported as more severe than other migraines, may persist longer, and may occur more frequently.11-14


Important Safety Information
FROVA® (frovatriptan succinate) is a triptan medication used to treat migraine headaches in adults. Only your doctor can decide if FROVA is right for you. Do not use FROVA if you have uncontrolled high blood pressure; have heart disease or a history of heart disease; have had a stroke; have circulation (blood flow) problems; or have hemiplegic or basilar migraine (if you are not sure about this, ask your doctor).

Cases of a potentially life-threatening serotonin syndrome have been reported with the use of triptan medications, including FROVA. Talk to your doctor before taking FROVA if you take selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs), two types of drugs for depression and other disorders. If you experience symptoms of serotonin syndrome, which may include mental status changes, rapid heartbeat, lack of coordination or muscle weakness, and/or gastrointestinal symptoms, contact your doctor or healthcare professional immediately.

Do not take FROVA if you have an allergic reaction to the tablet or within 24 hours of taking any triptans or ergotamine medications. The most common side effects associated with the use of FROVA are dizziness, tiredness, feeling of tingling, hot flashes, headache (other than migraine headache), dry mouth, hot or cold sensation, pain in joints or bones, chest pain, and indigestion.



References:
  1. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004;24(suppl 1):24-36; 138-149. Available at: http://216.25.100.131/ihscommon/guidelines/pdfs/ihc_II_main_no_print.pdf. Accessed January 19, 2007.
  2. American Council for Headache Education. Headache diary. Available at: http://www.achenet.org/resources/diary.php. Accessed February 21, 2007.
  3. National Headache Foundation. Serotonin. Available at: http://www.headaches.org/consumer/topicsheets/serotonin.html. Accessed February 21, 2007.
  4. American Council for Headache Education. Women and headaches. Available at: http://www.achenet.org/news/women.php. Accessed February 21, 2007.
  5. American Council for Headache Education. Migraine and coexisting conditions. Available at: http://www.achenet.org/news/macc.php. Accessed February 21, 2007.
  6. Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women’s hormonal migraine: the Depo-Estradiol challenge test. Headache. 1996;36:367-371.
  7. MacGregor EA. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004;3:354-361.
  8. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
  9. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 1993;33:385-389.
  10. Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade University. Headache. 2002;42:185-193.
  11. Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004;24:707-716.
  12. Couturier EGM, Bomhof MAM, Knuistingh Neven A, van Duijn NP. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia. 2003;23:302-308.
  13. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004;63:351-353.
  14. Martin VT, Wernke S, Mandell K, et al. Defining the relationship between ovarian hormones and migraine headache. Headache. 2005;45:1190-1201.


Intended for US residents only.
 Courtesy of frova.com

Endo® Pharmaceuticals
© 2007 Endo Pharmaceuticals. All rights reserved.
FROVA® is a registered trademark of Vernalis Development Limited.
Rx only
Print Print this page